C
Cytek Biosciences, Inc. (CTKB)
NMS – Real vaqt narxi. Valyuta: USD
4.04
-0.08 (-1.94%)
Yopilishda: May 12, 2026, 4:00 PM EDT
4.25
+0.21 (5.20%)
Bozor oldidan: May 13, 2026, 8:19 AM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NMS – Real vaqt narxi. Valyuta: USD
4.04
-0.08 (-1.94%)
Yopilishda: May 12, 2026, 4:00 PM EDT
4.25
+0.21 (5.20%)
Bozor oldidan: May 13, 2026, 8:19 AM EDT
This stock has a consensus price target of $5.70 based on the ratings of 6 analysts. The high is $7.50 and the low is $3.00.
| Maqsad | Min. maqsadli narx | O‘rtacha maqsadli narx | Maks. maqsadli narx |
|---|---|---|---|
| Narx | $ 3 | $ 5.7 | $ 7.5 |
| O’zgarish | -25.74% | 41.09% | 85.64% |
| Sana | O‘sish/pasayish potensiali | Tahlilchi firmasi | Maqsadli narx | Reyting o‘zgarishi | Reyting |
|---|---|---|---|---|---|
| 2026-01-08 | 17.65% | TD Cowen | $4 → $5 | Maintains | Buy |
| 2025-11-11 | 76.47% | Piper Sandler | $8 → $7.5 | Maintains | Overweight |
| 2025-05-28 | 64.71% | Morgan Stanley | $9 → $7 | Maintains | Equal-Weight |
| 2025-05-12 | -29.41% | Goldman Sachs | $3.5 → $3 | Maintains | Sell |
| 2025-03-19 | 41.18% | Stephens & Co. | $6 → $6 | Reiterates | Overweight |